Weekly Vitamin D in Pediatric IBD

Completed · Phase 1/Phase 2

Conditions studied: Inflammatory Bowel Diseases, Skin Pigmentation

In brief

The purpose of this study is to determine whether weekly dosing of oral vitamin D3 is effective in correcting low vitamin D levels in children and adolescents with inflammatory bowel disease (also known as Crohn's disease and ulcerative colitis).

Key facts

Study ID

NCT02076750

Run by

Emory University

People needed

34

Starts

2013-03-01

Expected to finish

2014-06-01

Last updated by the study team

2014-11-26

Who can join

Age: 8 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established diagnosis of inflammatory bowel disease made by a pediatric gastroenterologist and confirmed by histopathology
• Serum 25-OH vitamin D level <30 ng/mL at time of enrollment.
• Age 8-21 years
• Weight > 20 kg
• Parent, guardian, or subject (where applicable) able to give consent/assent

You may not qualify if…

• Inability to ingest oral vitamin D3 capsules
• Presence of known hepatobiliary disease
• Presence of known kidney disease or history of renal stones
• Use of systemic steroids within 60 days prior to enrollment.

Where it is running

• Children's Healthcare of Atlanta, Egleston Children's Hospital — Atlanta, Georgia, United States
• Emory Children's Center — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.